Skip to main content
. 2023 Nov 15;12(12):2807–2817. doi: 10.1007/s40121-023-00890-2

Table 3.

Demographic and clinical characteristics at first injection associated with any delayed CAB + RPV LA injections

n # delays (%) OR (95% CI)a aOR (95% CI)a
Age, per 10 years 321 75 (23) 0.95 (0.76, 1.18) 0.81 (0.61, 1.09)
Years since HIV diagnosis, per 10 years 321 75 (23) 1.04 (0.76, 1.42) 1.11 (0.73, 1.67)
Sex
 Female 53 15 (28) 1.48 (0.75, 2.90) 1.25 (0.52, 2.98)
 Male 268 60 (22) Ref Ref
Race
 Black 119 31 (26) 1.33 (0.77, 2.28) 1.22 (0.64, 2.32)
 Non-Black 193 42 (22) Ref Ref
 Missing 9 2 (22) NA NA
Ethnicity
 Hispanic 91 19 (21) 0.82 (0.44, 1.50) 0.82 (0.41, 1.65)
 Non- Hispanic 220 53 (24) Ref Ref
 Missing 10 3 (30) NA NA
Men who have sex with men
 Yes 200 43 (22) 0.80 (0.46, 1.37) 0.68 (0.32, 1.42)
 No 121 32 (26) Ref Ref
Injection drug use
 Any 7 2 (28) 1.29 (0.24, 6.81) 1.06 (0.19, 6.08)
 None 314 73 (23) Ref Ref
History of AIDS-defining events
 Any 69 25 (36) 2.33 (1.28, 4.23) 3.10 (1.54, 6.22)
 None 252 50 (20) Ref Ref
BMI
 > 30 kg/m2 91 21 (23) 1.05 (0.59, 1.89) 1.01 (0.54, 1.87)
 ≤ 30 kg/m2 230 54 (23) Ref Ref
CD4 cell count
 ≥ 500 cells/μL 217 48 (22) 0.75 (0.43, 1.32) 0.96 (0.51, 1.80)
 < 500 cells/μL 97 26 (27) Ref Ref
 Missing 7 1 (14) NA NA
Viral load
 ≥ 50 copies/mL 43 9 (21) 0.75 (0.33, 1.71) 0.50 (0.20, 1.23)
 < 50 copies/mL 273 65 (24) Ref Ref
 Missing 5 1 (20) NA NA

aOR adjusted odds ratio, CI confidence interval, BMI body mass index, n number, OR odds ratio